Motor Neuron Disease
Mostrando 1-12 de 162 artigos, teses e dissertações.
-
1. Relationship between oral transit time and functional performance in motor neuron disease
RESUMO O comprometimento na fase oral da deglutição na doença do neurônio motor (DNM) é ocasionado por fraqueza, fasciculação e atrofia de língua, podendo comprometer o tempo de trânsito oral (TTO) e o tempo total de alimentação. Objetivo: Descrever e relacionar o tempo de trânsito oral total (TTOT) com o desempenho funcional na DNM em distintas
Arq. Neuro-Psiquiatr.. Publicado em: 05/09/2019
-
2. Quantificação da lesão neuronal e mielínica na Esclerose Lateral Amiotrófica através da ressonância magnética / Quantification of myelin and neuronal damage in ALS using magnetic resonance imaging.
Introdução: A Esclerose Lateral Amiotrófica (ELA) é uma doença degenerativa e progressiva que afeta neurônios motores da medula espinhal, tronco cerebral e/ ou córtex motor. Sua manifestação clínica é bastante variada, sua etiologia desconhecida e a progressão, fatal. Não existe ainda um tratamento curativo para a ELA, porém alguns medicamentos
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 28/05/2012
-
3. Qualidade de vida relacionada à deglutição na esclerose lateral amiotrófica / Swallowing quality of life in amyotrophic lateral sclerosis
Esclerose Lateral Amiotrófica (ELA) é definida como uma doença neurodegenerativa, caracterizada por paralisia muscular progressiva dos membros, orofaringe e musculatura respiratória, com consequente disfagia, disartria e insuficiência respiratória devido a degeneração dos neurônios motores no córtex motor primário, no tronco cerebral e na medula e
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 07/11/2011
-
4. Epidemiology of amyotrophic lateral sclerosis patients in a centre in Buenos Aires
Sporadic amyotrophic lateral sclerosis (sALS) is considered a multifactorial disease with genetic and environmental factors causing motor neuron degeneration. OBJECTIVE: To describe the epidemiological and occupational characteristics of patients with sALS who attended the Ramos Mejía Hospital at Buenos Aires, Argentina. METHOD: We analyzed the medical reco
Arquivos de Neuro-Psiquiatria. Publicado em: 2011-12
-
5. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease
Sao Paulo Medical Journal. Publicado em: 2010
-
6. Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients
We have tested the hypothesis that restless leg syndrome (RLS) is related to quality of sleep, fatigue and clinical disability in multiple sclerosis (MS). The diagnosis of RLS used the four minimum criteria defined by the International Restless Legs Syndrome Study Group. Fatigue was assessed by the Fatigue Severity Scale (FSS >27), quality of sleep by the Pi
Brazilian Journal of Medical and Biological Research. Publicado em: 2008-10
-
7. Hereditary motor and autonomic neuronopathy 1 maps to chromosome 20q13.2-13.3
The spinal muscular atrophies (SMA) or hereditary motor neuronopathies result from the continuous degeneration and death of spinal cord lower motor neurons, leading to progressive muscular weakness and atrophy. We describe a large Brazilian family exhibiting an extremely rare, late-onset, dominant, proximal, and progressive SMA accompanied by very unusual ma
Brazilian Journal of Medical and Biological Research. Publicado em: 2004-11
-
8. Shy-Drager Syndrome : a functional protocol study of the Autonomic Nervous System in 3 cases / Sindrome de Shy-Drager : protocolo de estudo funcional do sistema nervoso autonomo em 3 casos clinicos
This study was motivated by the desire to better understand the autonomic functions in subjects clinically diagnosed as Shy-Drager syndrome. This syndrome was selected because it presents a disorder in the central autonomic structures of CNS. This degenerative disease represents a multiple disorders of CNS which include dysautonomia associated with pyramidal
Publicado em: 1984
-
9. Trace elements in the spinal cord and other tissues in motor neuron disease.
Trace elements were estimated in the spinal cord, liver and bone of five patients dying of motor neuron disease and five control subjects dying of non-neurological disease. The content of selenium in cord and liver and the cord manganese level were significantly increased in the motor neuron disease patients. These findings are discussed in terms of the poss
-
10. Central motor conduction is abnormal in motor neuron disease.
Conduction in the central motor pathways of the brain and spinal cord was studied in 12 patients with motor neuron disease. Six healthy volunteers served as controls. Transcutaneous electrical stimulation of the cortex, cervical cord, thoracic cord and conus medullaris was used to determine motor latencies to the biceps brachii, thenar eminence and tibialis
-
11. Motor neuron disease in a defined English population: estimates of incidence and mortality.
Linked statistics from hospital records and death certificates were used to study the incidence of and mortality from motor neuron disease in a defined English population. The incidence of motor neuron disease, measured as first-admission rates for the disease, was studied from 1963 to 1985 and death certificates for the patients admitted to hospital were ob
-
12. Motor neuron disease in England and Wales, 1959-1979.
Mortality rates from motor neuron disease in England and Wales for the years 1959-1979 were studied through death certification data supplied by the Office of Population Censuses and Surveys. The age- and sex-adjusted mortality rate increased over the period from 1.2 per 100 000 per year in 1959-61 to 1.6 in 1977-79, the increase being most apparent in women